Trial Profile
Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe recurrent vesicular hand eczema. A randomized prospective open-label trial with blinded outcome assessment
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Sep 2023
Price :
$35
*
At a glance
- Drugs Alitretinoin (Primary) ; Ciclosporin (Primary)
- Indications Eczema
- Focus Therapeutic Use
- Acronyms ALICsA
- 12 Sep 2023 Planned number of patients changed from 76 to 78.
- 24 Feb 2019 Planned End Date changed from 1 Mar 2020 to 1 Jul 2022.
- 24 Feb 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Jul 2022.